IP Library Granted Patent US 11,242,535
Granted Patent B2
US 11,242,535 · App. 16/429,846 · Granted Feb 8, 2022

Regulatory sequences for modulating transgene expression in plants

Inventors: Scott Diehn (West Des Moines, IA); Ajit Nott (Johnston, IA); David A Selinger (Hockessin, DE); Carl Simmons (Des Moines, IA); Priyanka Bhyri (Secunderabad, IN); Venkata S Tavva (Hyderabad, IN)
C12N15/8216
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,242,535
App. No.
16/429,846
Granted
Feb 8, 2022
Kind
B2
Abstract

The invention relates to gene expression regulatory sequences, specifically introns that act as enhancers of gene expression, the promoter and terminator sequences endogenously associated with these introns. Presence of these intronic enhancer sequences in proximity to promoter sequences leads to enhancement of gene expression. Methods of finding such new intronic enhancer sequences and using them to generate transgenic plants are also described.

Claims (12)

1. A recombinant DNA construct comprising: (a) an intron operably linked to a promoter, (b) a heterologous polynucleotide, and (c) a terminator, wherein the intron comprises a nucleotide sequence that has at least 98% sequence identity to SEQ ID NO: 13, and wherein the intron comprises at least one copy of a nucleotide sequence of SEQ ID NO: 100.

2. The recombinant DNA construct of claim 1 , wherein the intron comprises the nucleotide sequence of SEQ ID NO: 13.

3. The recombinant DNA construct of claim 1 , wherein the intron enhances expression of the heterologous polynucleotide in a plant.

4. The recombinant DNA construct of claim 1 , wherein the intron is capable of enhancing expression of a heterologous polynucleotide in a monocotyledonous plant when compared to a corresponding recombinant DNA construct without the intron.

5. A plant comprising the recombinant DNA construct of claim 3 .

6. A seed comprising the recombinant DNA construct of claim 3 .

7. A method for modulating transgene expression in a plant comprising the steps of:

(a) introducing into a regenerable plant cell the recombinant DNA construct of claim 1 ;

(b) regenerating a transgenic plant from the regenerable plant cell after step (a) wherein the transgenic plant comprises the recombinant DNA construct; and

(c) obtaining a progeny plant derived from the transgenic plant of step (b), wherein the progeny plant comprises the recombinant DNA construct and exhibits enhanced transgene expression when compared to a plant comprising in its genome the recombinant DNA construct without the corresponding intron sequence.

8. The method of claim 7 wherein said plant is a monocot.

9. The recombinant DNA construct of claim 1 , wherein said promoter is a constitutive promoter, a tissue-preferred promoter, an inducible promoter, or a developmentally regulated promoter.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Feb 21, 2024
From: E.I. DU PONT DE NEMOURS AND COMPANY
To: CORTEVA AGRISCIENCE LLC
Reel/Frame 066507/0548 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2021
From: DIEHN, SCOTT; SIMMONS, CARL R; NOTT, AJIT; BHYRI, PRIYANKA; TAVVA, VENKATA S; SELINGER, DAVID A
To: PIONEER HI-BRED INTERNATIONAL, INC.; E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 058467/0707 →
Priority Claims (1)
IN 1340/DEL/2010 · Jun 9, 2010 · national
Continuity (5)
Continuation 15660390 · Jul 26, 2017
Continuation 14660076 · Mar 17, 2015
Continuation 13701848
Provisional Application 61372515 · Aug 11, 2010
Related Publication 20190316142A1 · Oct 17, 2019
Cited By (1)
US 12,286,634